Authors: Hasenclever, D Brosteanu, O Gerike, T Loeffler, M

Citation: D. Hasenclever et al., Modelling of chemotherapy: The effective dose approach, ANN HEMATOL, 80, 2001, pp. B89-B94

Authors: Duhmke, E Franklin, J Pfreundschuh, M Sehlen, S Willich, N Ruhl, U Muller, RP Lukas, P Atzinger, A Paulus, U Lathan, B Ruffer, U Sieber, M Wolf, J Engert, A Georgii, A Staar, S Herrmann, R Beykirch, M Kirchner, H Emminger, A Greil, R Fritsch, E Koch, P Drochtert, A Brosteanu, O Hasenclever, D Loeffler, M Diehl, V

Citation: E. Duhmke et al., Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: Long-term results of a randomized trial of radiotherapy alone, J CL ONCOL, 19(11), 2001, pp. 2905-2914

Authors: Loeffler, M Brosteanu, O Hasenclever, D

Citation: M. Loeffler et al., MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: Analysis of a meta-analysis by clinicians - In reply, J CL ONCOL, 17(2), 1999, pp. 732-734